Scholars@Duke
Journal cover image

Absolute and relative truth in clinical trials.

Publication ,  Journal Article
Julian, D
Published in: Lancet
June 1, 2002
Published version (DOI) Link to item

Duke Scholars

Paul Wayne Armstrong
Author Paul Wayne Armstrong Medicine, Cardiology
Robert M. Califf
Author Robert M. Califf Medicine, Cardiology

Published In

Lancet

DOI

10.1016/S0140-6736(02)08750-0

ISSN

0140-6736

Publication Date

June 1, 2002

Volume

359

Issue

9321

Start / End Page

1945 / 1946

Location

England

Related Subject Headings

  • Reproducibility of Results
  • Recombinant Proteins
  • Randomized Controlled Trials as Topic
  • Peptide Fragments
  • Myocardial Infarction
  • Humans
  • Hirudins
  • Hirudin Therapy
  • Heparin
  • General & Internal Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Julian, D. (2002). Absolute and relative truth in clinical trials. Lancet, 359(9321), 1945–1946. https://doi.org/10.1016/S0140-6736(02)08750-0
Julian, Desmond. “Absolute and relative truth in clinical trials.” Lancet 359, no. 9321 (June 1, 2002): 1945–46. https://doi.org/10.1016/S0140-6736(02)08750-0.
Julian D. Absolute and relative truth in clinical trials. Lancet. 2002 Jun 1;359(9321):1945–6.
Julian, Desmond. “Absolute and relative truth in clinical trials.” Lancet, vol. 359, no. 9321, June 2002, pp. 1945–46. Pubmed, doi:10.1016/S0140-6736(02)08750-0.
Julian D. Absolute and relative truth in clinical trials. Lancet. 2002 Jun 1;359(9321):1945–1946.
Journal cover image

Published In

Lancet

DOI

10.1016/S0140-6736(02)08750-0

ISSN

0140-6736

Publication Date

June 1, 2002

Volume

359

Issue

9321

Start / End Page

1945 / 1946

Location

England

Related Subject Headings

  • Reproducibility of Results
  • Recombinant Proteins
  • Randomized Controlled Trials as Topic
  • Peptide Fragments
  • Myocardial Infarction
  • Humans
  • Hirudins
  • Hirudin Therapy
  • Heparin
  • General & Internal Medicine